tiprankstipranks
Rohto Pharmaceutical Co Ltd (JP:4527)
:4527
Japanese Market
4527
Rohto Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4527 full AI Analyst Report?

Rohto Pharmaceutical Co (4527) Ratios

2 Followers

Rohto Pharmaceutical Co Ratios

JP:4527's free cash flow for Q1 2026 was ¥0.55. For the 2026 fiscal year, JP:4527's free cash flow was decreased by ¥ and operating cash flow was ¥0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 26Mar 25Mar 24
Liquidity Ratios
Current Ratio
 2.04 2.30 2.04 2.47 2.37
Quick Ratio
 1.48 1.65 1.48 1.93 1.86
Cash Ratio
 0.74 0.82 0.74 1.02 1.00
Solvency Ratio
 0.31 0.29 0.31 0.40 0.36
Operating Cash Flow Ratio
 0.00 0.39 0.41 0.39 0.39
Short-Term Operating Cash Flow Coverage
 0.00 3.40 1.93 6.46 7.40
Net Current Asset Value
¥ 73.68B¥ 67.45B¥ 73.68B¥ 115.62B¥ 95.64B
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.15 0.12 0.03 0.04
Debt-to-Equity Ratio
 0.20 0.24 0.20 0.04 0.06
Debt-to-Capital Ratio
 0.17 0.19 0.17 0.04 0.05
Long-Term Debt-to-Capital Ratio
 0.09 0.14 0.09 0.02 0.03
Financial Leverage Ratio
 1.61 1.62 1.61 1.41 1.48
Debt Service Coverage Ratio
 1.76 3.41 1.76 7.32 7.79
Interest Coverage Ratio
 31.70 40.53 31.70 204.33 137.49
Debt to Market Cap
 0.09 0.11 0.10 0.02 0.02
Interest Debt Per Share
 272.24 272.96 272.29 46.86 52.34
Net Debt to EBITDA
 -0.46 -0.31 -0.46 -1.56 -1.61
Profitability Margins
Gross Profit Margin
55.46%54.91%53.23%58.07%57.58%
EBIT Margin
11.84%12.46%11.84%15.40%14.47%
EBITDA Margin
16.90%16.72%16.90%18.61%17.74%
Operating Profit Margin
11.84%12.46%11.84%14.79%14.23%
Pretax Profit Margin
13.62%13.72%13.62%15.33%14.37%
Net Profit Margin
9.96%10.05%9.96%11.42%11.05%
Continuous Operations Profit Margin
10.01%10.03%10.01%11.59%11.07%
Net Income Per EBT
73.15%73.24%73.15%74.51%76.92%
EBT Per EBIT
115.02%110.05%115.02%103.67%100.97%
Return on Assets (ROA)
7.05%7.35%7.05%8.94%8.52%
Return on Equity (ROE)
12.11%11.92%11.35%12.56%12.59%
Return on Capital Employed (ROCE)
11.05%11.75%11.05%15.46%14.80%
Return on Invested Capital (ROIC)
7.61%8.32%7.61%11.45%11.20%
Return on Tangible Assets
8.52%8.48%8.52%9.18%8.79%
Earnings Yield
6.05%6.09%6.30%4.51%4.17%
Efficiency Ratios
Receivables Turnover
 4.47 4.42 4.47 3.92 3.93
Payables Turnover
 6.76 6.31 7.10 5.38 5.41
Inventory Turnover
 2.33 2.26 2.45 2.43 2.47
Fixed Asset Turnover
 3.70 3.41 3.70 3.95 3.61
Asset Turnover
 0.71 0.73 0.71 0.78 0.77
Working Capital Turnover Ratio
 2.92 2.46 2.80 2.28 2.35
Cash Conversion Cycle
 184.21 186.31 179.30 175.22 173.32
Days of Sales Outstanding
 81.60 82.64 81.60 93.14 92.76
Days of Inventory Outstanding
 156.60 161.52 149.11 149.97 148.04
Days of Payables Outstanding
 54.00 57.85 51.41 67.90 67.48
Operating Cycle
 238.20 244.16 230.71 243.11 240.80
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 162.06 211.49 150.11 135.55
Free Cash Flow Per Share
 0.00 122.20 160.62 111.04 92.12
CapEx Per Share
 0.00 39.86 50.87 39.06 43.43
Free Cash Flow to Operating Cash Flow
 0.00 0.75 0.76 0.74 0.68
Dividend Paid and CapEx Coverage Ratio
 0.00 2.29 2.30 2.38 2.12
Capital Expenditure Coverage Ratio
 0.00 4.07 4.16 3.84 3.12
Operating Cash Flow Coverage Ratio
 0.00 0.60 0.79 3.26 2.64
Operating Cash Flow to Sales Ratio
 0.00 0.12 0.14 0.13 0.13
Free Cash Flow Yield
0.00%5.46%6.67%3.70%3.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 16.60 16.43 15.88 22.15 23.96
Price-to-Sales (P/S) Ratio
 1.65 1.65 1.58 2.53 2.65
Price-to-Book (P/B) Ratio
 1.88 1.96 1.80 2.78 3.02
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 18.30 14.99 27.05 30.07
Price-to-Operating Cash Flow Ratio
 0.00 13.80 11.38 20.01 20.44
Price-to-Earnings Growth (PEG) Ratio
 1.49 43.69 1.40 1.28 0.96
Price-to-Fair Value
 1.88 1.96 1.80 2.78 3.02
Enterprise Value Multiple
 9.33 9.56 8.91 12.04 13.31
Enterprise Value
 539.81B 493.56B 517.44B 606.61B 563.69B
EV to EBITDA
 9.29 9.56 8.91 12.04 13.31
EV to Sales
 1.57 1.60 1.51 2.24 2.36
EV to Free Cash Flow
 0.00 17.73 14.26 23.95 26.82
EV to Operating Cash Flow
 0.00 13.37 10.83 17.71 18.23
Tangible Book Value Per Share
 1.05K 945.43 1.05K 1.04K 900.83
Shareholders’ Equity Per Share
 1.34K 1.14K 1.34K 1.08K 918.60
Tax and Other Ratios
Effective Tax Rate
 0.26 0.27 0.26 0.24 0.23
Revenue Per Share
 1.52K 1.35K 1.52K 1.19K 1.05K
Net Income Per Share
 151.54 136.10 151.56 135.60 115.62
Tax Burden
 0.73 0.73 0.73 0.75 0.77
Interest Burden
 1.15 1.10 1.15 1.00 0.99
Research & Development to Revenue
 0.04 0.05 0.04 0.04 0.05
SG&A to Revenue
 0.40 0.38 0.37 0.17 0.18
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.19 1.40 1.11 0.90
Currency in JPY